Group 1 - The innovative drug sector experienced an initial adjustment, with several companies, including Aosaikang, hitting the daily limit down [1] - Other companies such as Guangshengtang, Jimin Health, Huilong Pharmaceutical-W, Saili Medical, Rongchang Bio, and Wanbangde also saw declines [1]

Market Overview - The chemical pharmaceutical sector increased by 0.39% on September 25, with Aosaikang leading the gains [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Top Gainers in Chemical Pharmaceutical Sector - Aosaikang (002755) closed at 23.28, up 10.02% with a trading volume of 126,300 shares and a turnover of 286 million [1] - Guangshengtang (300436) closed at 121.57, up 9.37% with a trading volume of 235,500 shares and a turnover of 2.802 billion [1] - Naimi Technology (688690) closed at 27.99, up 6.02% with a trading volume of 94,700 shares and a turnover of 26.1 million [1] Top Losers in Chemical Pharmaceutical Sector - Mengke Pharmaceutical (688373) closed at 8.61, down 10.96% with a trading volume of 717,800 shares [2] - Borui Pharmaceutical (688166) closed at 66.41, down 8.40% with a trading volume of 239,000 shares [2] - Haichen Pharmaceutical (300584) closed at 57.90, down 5.95% with a trading volume of 103,000 shares [2] Capital Flow Analysis - The chemical pharmaceutical sector experienced a net outflow of 858 million from institutional investors, while retail investors saw a net inflow of 538 million [2] - The top stocks by net inflow from institutional investors included Guangshengtang with 325 million and Aosaikang with 97.5934 million [3] - Retail investors showed significant interest in Aosaikang, with a net outflow of 66.8017 million [3]

Core Points - The Shanghai Composite Index closed at 3859.62 points, above the five-day moving average, with a slight increase of 0.16% [1] - A total trading volume of A-shares reached 1,555.781 billion yuan, with 655 A-shares breaking through the five-day moving average [1] Summary by Category Stock Performance - The top three stocks with the highest deviation rates from the five-day moving average are: - Ha Huanhua (301137) with a deviation rate of 15.31% and a price increase of 19.99% [2] - Naipu Mining (300818) with a deviation rate of 15.09% and a price increase of 19.99% [2] - Yi Wang Yi Chuang (300792) with a deviation rate of 13.35% and a price increase of 19.99% [2] Trading Metrics - The trading turnover rates for the top three stocks with the highest deviation rates are: - Ha Huanhua (301137) at 11.45% [2] - Naipu Mining (300818) at 11.58% [2] - Yi Wang Yi Chuang (300792) at 16.97% [2] Additional Stocks - Other notable stocks with significant performance include: - Heng Er Da (300946) with a deviation rate of 13.19% and a price increase of 17.77% [2] - Ningbo Construction (601789) with a deviation rate of 8.35% and a price increase of 9.96% [2] - Jiaze New Energy (601619) with a deviation rate of 7.69% and a price increase of 9.98% [2]

Market Overview - The Shanghai Composite Index is at 3854.14 points, slightly above the five-day moving average, with a change of 0.01% [1] - The total trading volume of A-shares is 1,140.591 billion yuan [1] Stocks Performance - A total of 796 A-shares have surpassed the five-day moving average today [1] - Stocks with significant deviation rates include: - HaHuanHuaTong (15.31% deviation) with a price increase of 19.99% and a turnover rate of 11.08% [1] - NaiPuMiner (15.09% deviation) with a price increase of 19.99% and a turnover rate of 11.23% [1] - YiWangYiChuang (12.15% deviation) with a price increase of 18.36% and a turnover rate of 14.41% [1] Additional Notable Stocks - HengErDa shows a 9.05% deviation with a price increase of 12.27% [1] - NingBoJianGong has a deviation of 8.35% with a price increase of 9.96% [1] - Other stocks with notable performance include JiaZeXinNeng (7.69% deviation) and GuangDianDianQi (7.67% deviation) [1]

（文章来源：证券日报） 证券日报网讯奥赛康9月22日在互动平台回答投资者提问时表示，截至9月10日，公司的股东人数为19， 565户。 ...

Core Viewpoint - Jiangsu Suyang Investment Co., Ltd. has reduced its stake in Aosaikang Pharmaceutical Co., Ltd. by 10,160,232 shares, representing 1.09% of the total share capital, from February 27, 2025, to September 12, 2025, due to its own operational needs [2][3]. Group 1: Shareholding Changes - Jiangsu Suyang Investment's shareholding decreased from 14.00% to 12.91%, triggering a 1% change in equity [3]. - The reduction was executed through centralized bidding and block trading, in accordance with a previously disclosed reduction plan [3]. Group 2: Impact on Aosaikang - The share reduction will not lead to a change in control of Aosaikang, and the management team remains stable [4]. - Aosaikang will continue to focus on its established strategy in pharmaceutical research, production, and sales, ensuring the provision of quality medicines to the market [4]. Group 3: Financial Performance - Aosaikang reported a revenue of 1.007 billion yuan for the first half of 2025, reflecting a year-on-year growth of 9.20% [5]. - The net profit attributable to shareholders reached 160 million yuan, marking a significant year-on-year increase of 111.64% [5].

证券代码：002755 证券简称：奥赛康 公告编号：2025-050 北京奥赛康药业股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载，误导性陈述或重大遗漏。 特别提示 1、本次股东大会无增加、变更、否决提案的情况； 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开情况 1、股东大会届次：2025 年第二次临时股东大会 3、会议召开的合法、合规性：本次股东大会的召集、召开符合《公司法》 《上市公司股东会规则》等有关法律法规、部门规章、规范性文件和《公司章程》 的规定。 4、会议召开的日期、时间： （1）现场会议时间：2025 年 9 月 19 日（星期五）14:00 （2）网络投票时间：2025 年 9 月 19 日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 9 月 19 日 9:15－9:25，9:30－11:30，13:00－15:00；通过深圳证券交易所互联网投 票系统投票的具体时间为 2025 年 9 月 19 日 9:15－15:00 期间的任意时间。 5、现场会议地点：南京江 ...

国浩律师（南京）事务所 关于北京奥赛康药业股份有限公司 2025 年第二次临时股东大会的 中国江苏省南京市汉中门大街 309 号 B 座 5、7-8 层 邮编：210036 5、7-8/F, Block B, 309 Hanzhongmen Dajie, Nanjing, China, 210036 电话/Tel: +86 25 8966 0900 传真/Fax: +86 2589660966 网址/Website: http://www.grandall.com.cn 2025 年 9 月 国浩律师（南京）事务所 法律意见书 国浩律师（南京）事务所 关于北京奥赛康药业股份有限公司 国浩律师（南京）事务所 法律意见书 法律意见书 2025 年第二次临时股东大会的 法律意见书 致：北京奥赛康药业股份有限公司 国浩律师（南京）事务所（以下简称"本所"）接受北京奥赛康药业股份有限公 司（以下简称"公司"）的委托，就公司 2025 年第二次临时股东大会（以下简称"本 次股东大会"、"会议"）召开的有关事宜，根据《中华人民共和国公司法》（以下简 称"《公司法》"）、中国证券监督管理委员会发布的《上市公司股东会规则》（以 ...

Core Viewpoint - The company Aosaikang (002755.SZ) has received a notice from its shareholder Jiangsu Suyang Investment Industrial Co., Ltd. regarding a significant reduction in shareholding [1] Shareholding Changes - Jiangsu Suyang Investment has reduced its shareholding by a total of 10,160,232 shares, which accounts for 1.09% of the company's total share capital [1] - Prior to this reduction, Jiangsu Suyang Investment held 129,942,392 shares, representing 14.00% of the total share capital [1] - After the reduction, Jiangsu Suyang Investment now holds 119,782,160 shares, which is 12.91% of the total share capital [1]

证券代码：002755 证券简称：奥赛康 公告编号：2025-049 北京奥赛康药业股份有限公司 持股 5%以上股东股份变动触及 1%的公告 1．基本情况 信息披露义务人 江苏苏洋投资实业有限公司 住所 南京市江宁区秣陵街道科学园龙眠大道 618 号 权益变动时间 2025 年 2 月 27 日-2025 年 9 月 12 日 权益变动过程 苏洋投资出于自身经营发展需要，于 2025 年 2 月 27 日至 2025 年 9 月 12 日通过集中竞价和大宗交易方式 共减持公司股份 10,160,232 股，减持后，苏洋投资持 股比例由 14.00%下降至 12.91%，权益变动触及 1%。 苏洋投资减持股份是按照已披露的减持计划进行，本 一、股份变动情况 | 次减持股份不会导致公司控制权发生变更，不会对公 | | | | | | | --- | --- | --- | --- | --- | --- | | 司的经营产生重大影响。 | | | | | | | 股票简称 奥赛康 | | 股票代码 | | 002755 | | | 变动方向 上升□ 下降 | 有□ | 一致行动人 | | 无 | | | 是否 ...